US stocks soared | Regenesis Corporation (RGC.US) surged over 61%, with a market value of $670 million.

According to the Securities Times app, MindRegen Science and Technology (RGC.US) soared over 61% on Wednesday to $51 per share, with a market value of $670 million. It is reported that MindRegen Science and Technology is an early-stage biotechnology company focused on the research and commercialization of traditional Chinese medicine for the treatment of neurocognitive disorders and degenerative changes, especially ADHD and ASD.